Kelly Harchut et al | 10 May 2013 | Malaria Journal
Early and accurate diagnosis of febrile patients is essential to treat uncomplicated malaria cases properly, prevent severe malaria, and avert unnecessary anti-malarial treatments.
Khumbulani W Hlongwana | 23 Apr 2013 | Parasites & Vectors
Contradictory arguments regarding the benefits and harm of insecticides, especially DDT, have caused concerns in different societal circles, threatening to undermine the achievements of the indoor residual spraying (IRS) programme in South Africa.
Anthony K Mbonye et al | 16 Apr 2013 | Malaria Journal
Since drug shops play an important role in treatment of fever, introducing rapid diagnostic tests (RDTs) for malaria at drug shops may have the potential of targeting anti-malarial drugs to those with malaria parasites and improve rational drug use
Jianhai Yin et al | 15 Apr 2013 | Malaria Journal
China is implementing a National Malaria Elimination Programme.
Khamis A Haji et al | 28 Mar 2013 | Parasites & Vectors
The sustainability of the gains achieved in malaria control in Zanzibar is seriously threatened by the resistance of malaria vectors to pyrethroids and the short-lived efficacy of LLINs.
Ulrika Morris et al | 19 Mar 2013 | Malaria Journal
The need for new malaria surveillance tools and strategies is critical, given improved global malaria control and regional elimination efforts.
Julie A Bauch et al | 22 Feb 2013 | Malaria Journal
Malaria transmission has declined dramatically in Zanzibar in recent years.
Nancy Fullman et al | 13 Feb 2013 | Malaria Journal
Malaria control programmes currently face the challenge of maintaining, as well as accelerating, the progress made against malaria with fewer resources and uncertain funding.
Sylla Thiam et al | 05 Feb 2013 | Malaria Journal
The National Malaria Control Programme in Senegal, introduced since 2006, artemisinin-based combination therapy (ACT administration) for the treatment of uncomplicated malaria cases.
Mathieu Ndounga et al | 05 Feb 2013 | Malaria Journal
Congo-Brazzaville adopted artemisinin-based combination therapy (ACT) in 2006. Artesunate-amodiaquine (AS + AQ) and artemether-lumefantrine are the first-line and second-line anti-malarial drugs to treat uncomplicated Plasmodium falciparum malaria, respectively. The baseline efficacy of AS + AQ was evaluated from February to August 2005 in patients living in Brazzaville, the capital city of the Republic of Congo.